Description
FORMA FARMACÉUTICA: 14 CAPSULAS
1 frasco ámpula con 400 mg de daratumumab en solución inyectable
un tratamiento dirigido para el carcinoma urotelial irresecable o metastásico en pacientes adultos que presentan mutaciones en los genes FGFR2 o FGFR3
Rinitis alérgica estacional y perenne
Leucopenia
KOLESTON TINT CRA NGRO N20 VALERIANA 1.00 S/G PASIFLORA 1.00 S/G IGNATIA 1.00 UN FORMA FARMACÉUTICA: 14 CAPSULAS
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
